| Ident. | Authors (with country if any) | Title |
|---|
| 001329 (2012) |
Susan H. Fox [Canada] ; Tom H. Johnston [Canada] ; Qin Li [République populaire de Chine] ; Jonathan Brotchie [Canada] ; Erwan Bezard [République populaire de Chine, France] | A critique of available scales and presentation of the non‐human primate dyskinesia rating scale |
| 002C47 (2005) |
Pierre-Olivier Fernagut [États-Unis] ; Imad Ghorayeb [France] ; Elsa Diguet [France] ; François Tison [France] | In vivo models of multiple system atrophy |
| 002E68 (2004) |
Anita Sidhu [États-Unis] ; Christophe Wersinger [États-Unis] ; Charbel E-H. Moussa [États-Unis] ; Philippe Vernier [France] | The Role of α‐Synuclein in Both Neuroprotection and Neurodegeneration |
| 002F24 (2004) |
Elsa Diguet [France] ; Pierre-Olivier Fernagut [France, États-Unis] ; Xing Wei [États-Unis] ; Yansheng Du [États-Unis] ; Richard Rouland [France] ; Christian Gross [France] ; Erwan Bezard [France] ; François Tison [France] | Deleterious effects of minocycline in animal models of Parkinson's disease and Huntington's disease |
| 003680 (2001) |
Karine Parain [France] ; Véronique Marchand [France] ; Bernard Dumery [France] ; Etienne Hirsch [France] | Nicotine, but not cotinine, partially protects dopaminergic neurons against MPTP-induced degeneration in mice |
| 003687 (2001) |
David Blum [Belgique, France] ; Sakina Torch [France] ; Nathalie Lambeng [France] ; Marie-France Nissou [France] ; Alim-Louis Benabid [France] ; Rémy Sadoul [France] ; Jean-Marc Verna [France] | Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease |
| 003747 (2001) |
Hélène Turmel [France] ; Andreas Hartmann [France] ; Karine Parain [France] ; Aicha Douhou [France] ; Anu Srinivasan [États-Unis] ; Yves Agid [France] ; Etienne C. Hirsch [France] | Caspase‐3 activation in 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)‐treated mice |
| 003757 (2001) |
C. Chassain [France] ; A. Eschalier [France] ; F. Durif [France] | Assessment of motor behavior using a video system and a clinical rating scale in parkinsonian monkeys lesioned by MPTP |
| 003977 (2000) |
Sophie Callier [Canada, France] ; Marc Morissette [Canada] ; Michelle Grbois [Canada] ; Thérèse Di Paolo [Canada] | Stereospecific prevention by 17β‐estradiol of MPTP‐induced dopamine depletion in mice |
| 003D93 (1999) |
Martin Goulet ; Marc Morissette ; Richard Grondin ; Pierre Falardeau ; Paul J. Bédard ; William Rostène [France] ; Thérèse Di Paolo | Neurotensin receptors and dopamine transporters: Effects of MPTP lesioning and chronic dopaminergic treatments in monkeys |
| 003E47 (1999) |
Erwan Bezard [France] ; Christian E. Gross [France] ; Marie-Christine Fournier [France] ; Sandra Dovero [France] ; Bertrand Bloch [France] ; Mohamed Jaber [France] | Absence of MPTP-Induced Neuronal Death in Mice Lacking the Dopamine Transporter |
| 004581 (1996) |
P. Barnéoud [France] ; M. Mazadier [France] ; J.-M. Miquet [France] ; S. Parmentier [France] ; P. Dubédat [France] ; A. Doble [France] ; A. Boireau [France] | Neuroprotective effects of riluzole on a model of parkinson's disease in the rat |
| 004586 (1996) |
M. Vila [France] ; R. Levy [France] ; M.-T. Herrero [Espagne] ; B. Faucheux [France] ; J. A. Obeso [Espagne] ; Yves Agid [France] ; E. C. Hirsch [France] | Metabolic activity of the basal ganglia in parkinsonian syndromes in human and non-human primates: A cytochrome oxidase histochemistry study |
| 004594 (1996) |
O.-K. Hassani [France] ; M. Mouroux [France] ; J. Féger [France] | Increased subthalamic neuronal activity after nigral dopaminergic lesion independent of disinhibition via the globus pallidus |
| 004629 (1996) |
Abdelhamid Benazzouz [France] ; Thomas Boraud [France] ; Jean Féger [France] ; Pierre Burbaud [France] ; Bernard Bioulac [France] ; Christian Gross [France] | Alleviation of experimental hemiparkinsonism by high‐frequency stimulation of the subthalamic nucleus in primates: A comparison with L‐dopa treatment |
| 004842 (1995) |
B. A. Faucheux [France] ; M. T. Herrero [Espagne] ; J. Villares [France] ; R. Levy [France] ; F. Javoy-Agid [France] ; J. A. Obeso [Espagne] ; J. J. Hauw [France] ; Yves Agid [France] ; E. C. Hirsch [France] | Autoradiographic localization and density of [125I]ferrotransferrin binding sites in the basal ganglia of control subjects, patients with Parkinson's disease and MPTP-lesioned monkeys |
| 004B69 (1993) |
P. Hantraye [France] ; M. Varastet [France] ; M. Peschanski [France] ; D. Riche [France] ; P. Cesaro [France] ; J. C. Willer [France] ; M. Maziere [France] | Stable parkinsonian syndrome and uneven loss of striatal dopamine fibres following chronic MPTP administration in baboons |
| 004B88 (1993) |
M. T. Herrero [France] ; E. C. Hirsch [France] ; A. Kastner [France] ; M. Ruberg [France] ; M. R. Luquin [Espagne] ; J. Laguna [Espagne] ; F. Javoy-Agid [France] ; J. A. Obeso [Espagne] ; Yves Agid [Espagne] | Does neuromelanin contribute to the vulnerability of catecholaminergic neurons in monkeys intoxicated with MPTP? |
| 004B89 (1993) |
M. T. Herrero [France] ; E. C. Hirsch [France] ; F. Javoy-Agid [France] ; J. A. Obeso [Espagne] ; Yves Agid [France] | Differential vulnerability to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine of dopaminergic and cholinergic neurons in the monkey mesopontine tegmentum |
| 004F44 (1991) |
K. Kitahama [France] ; R. M. Denney [États-Unis] ; T. Maeda [Japon] ; M. Jouvet [France] | Distribution of type B monoamine oxidase immunoreactivity in the cat brain with reference to enzyme histochemistry |
| 005062 (1990) |
P. P. Michel [États-Unis, France] ; P. P. Hefti [États-Unis] | Toxicity of 6‐hydroxydopamine and dopamine for dopaminergic neurons in culture |
